CECAD Cluster of Excellence for Aging Research
Developing new therapies for aging realted diseases.
CECAD’s vision is to use the knowledge gained to develop new therapies
for the entire spectrum of aging-associated diseases, including cancer,
diabetes, stroke, renal failure, and neurodegenerative disorders.
CECAD creates new synergies through a novel network of innovative minds
and ideas. More than 400 international scientists from the University of
Cologne, the Cologne University Hospital, the Max Planck Institutes for
Metabolism Research and Biology of Ageing, and the German Center for
Neurodegenerative Diseases (DZNE) are exploring the molecular basis of
the aging process and age-associated diseases at the Cluster of
Excellence.
Visit website: https://www.cecad.uni-koeln.de/home/
Details last updated 22-Nov-2019
CECAD Cluster of Excellence for Aging Research News
Aging measured by randomness in cells, study finds
CECAD Cluster of Excellence for Aging Research - 09-May-2024
Random cellular chaos offers new hope for anti-ageing interventions
Read more...Ageing speeds up gene reading, reducing its accuracy
University of Cologne - 12-Apr-2023
Calorie restriction may extend lifespan by improving the quality of gene transcription
Read more...14 biomarkers indicate the remaining lifespan of an individual
Medical Xpress - 21-Aug-2019
Accuracy of mortality risk prediction is high when using this method
Read more...